On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
On Jan. 20, 2005, the Siteman Cancer Center received National Cancer Institute (NCI) designation as a Comprehensive Cancer…
In 2004, the Oklahoma Medical Research Foundation (OMRF) opened the state’s first small animal magnetic resonance imaging facility….
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
On Jun. 21, 2004, the Huntsman Cancer Center Hospital was dedicated featuring a full-field digital mammography unit, a…
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
In 2003, the Institute for Research in Immunology and Cancer (IRIC) was created at the University of Montreal…
On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
On Jul. 17, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…